Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2018 2
2020 3
2021 3
2022 2
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Latin American Consensus on the Treatment of Head and Neck Cancer.
Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, de Castro Junior G, Farias TP, Bardales GS, Cabrera MA, Capuzzo RC, de Carvalho GB, Cernea CR, Dedivitis RA, Dias FL, Estefan AM, Falco AH, Ferraris GA, Gonzalez-Motta A, Gouveia AG, Jacinto AA, Kulcsar MAV, Leite AK, Lira RB, Mak MP, De Marchi P, de Mello ES, de Matos FCM, Montero PH, de Moraes ED, de Moraes FY, Morais DCR, Poenitz FM, Poitevin A, Riveros HO, Sanabria Á, Ticona-Castro M, Vartanian JG, Viani G, Vines EF, William Junior WN, Conway D, Virani S, Brennan P; HEADSpAcE Consortium. Matos LL, et al. Among authors: de oliveira tb. JCO Glob Oncol. 2024 Apr;10:e2300343. doi: 10.1200/GO.23.00343. JCO Glob Oncol. 2024. PMID: 38603656 Review.
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database.
Baliga S, Abou-Foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Blakaj D, Brennan S, Brunet A, De Oliveira TB, Burtness B, Maseda AC, Chow VL, Chua ML, de Ridder M, Garikipati S, Hanai N, Ho FCH, Huang SH, Kiyota N, Klinghammer K, Kowalski LP, Kwong DL, McDowell LJ, Merlano MC, Nair S, Economopoulou P, Overgaard J, Psyrri A, Tribius S, Waldron J, Yom SS, Mehanna H. Baliga S, et al. Among authors: de oliveira tb. Eur J Cancer. 2024 May;203:114038. doi: 10.1016/j.ejca.2024.114038. Epub 2024 Mar 30. Eur J Cancer. 2024. PMID: 38579517 Free article.
Differentiated thyroid carcinoma: what the nonspecialists needs to know.
Hoff AO, Chaves ALF, de Oliveira TB, Ramos HE, Penna GC, Dos Santos LV, Maia AL, Brito DO, Vizzotto FP. Hoff AO, et al. Among authors: de oliveira tb. Arch Endocrinol Metab. 2024 Feb 29;68:e230375. doi: 10.20945/2359-4292-2023-0375. Arch Endocrinol Metab. 2024. PMID: 38427812 Free PMC article. Review.
The impact of colonialism on head and neck cancer in Brazil: a historical essay focussing on tobacco, alcohol and slavery.
Figueiredo Lebre Martins BN, Dos Santos ES, Fonseca FP, William WN Jr, Bueno de Oliveira T, Marta GN, Freitas Chaves AL, Prado-Ribeiro AC, Ayo-Yusuf O, Curado MP, Saes AM, Kowalski LP, Santos-Silva AR; Latin American Cooperative Oncology Group; Brazilian Group of Head and Neck Cancer. Figueiredo Lebre Martins BN, et al. Among authors: bueno de oliveira t. Lancet Reg Health Am. 2024 Feb 9;31:100690. doi: 10.1016/j.lana.2024.100690. eCollection 2024 Mar. Lancet Reg Health Am. 2024. PMID: 38370581 Free PMC article. Review.
Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment.
Corassa M, Abreu RF, de Lima VCC, Torrezan GT, Cavalher FP, Silva TN, Oliveira TB, Freitas HC, Carraro DM, Costa FD. Corassa M, et al. Among authors: oliveira tb. JCO Precis Oncol. 2022 Oct;6:e2200367. doi: 10.1200/PO.22.00367. JCO Precis Oncol. 2022. PMID: 36201715 No abstract available.
NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF, Oliveira TB, Hertzler H, Toledo RN, D'Almeida Costa F, Lopes Pinto CA, Nunes WA, Nascimento AF, French CA, Nascimento AG. Abreu RF, et al. Among authors: oliveira tb. Hum Pathol. 2022 Aug;126:87-99. doi: 10.1016/j.humpath.2022.05.015. Epub 2022 May 24. Hum Pathol. 2022. PMID: 35623465
Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice.
Falco A, de Oliveira TB, Cacicedo J, Ospina AV, Ticona MÁ, Galindo H, Pereira MD, Aguilar-Ponce JL, Rueda-Domínguez A, Soria T, Taberna M, Iglesias L, Sowley T, Mesía R; TTCC group (Spanish Group for the Treatment of the Head and Neck Cancer). Falco A, et al. Among authors: de oliveira tb. Cancer Manag Res. 2021 Aug 26;13:6689-6703. doi: 10.2147/CMAR.S322411. eCollection 2021. Cancer Manag Res. 2021. PMID: 34471383 Free PMC article. Review.
Induction Chemotherapy for Advanced Oral Cavity Cancer.
de Oliveira TB, Marta GN, de Castro Junior G, Kowalski LP. de Oliveira TB, et al. Curr Oncol Rep. 2021 Aug 27;23(11):129. doi: 10.1007/s11912-021-01119-6. Curr Oncol Rep. 2021. PMID: 34453267 Review.
Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
Bueno de Oliveira T, Camila Braun A, Ribaldo Nicolau U, Ali Abdallah E, da Silva Alves V, Hugo Fonseca de Jesus V, Fernando Calsavara V, Paulo Kowaslki L, Domingos Chinen LT. Bueno de Oliveira T, et al. Oral Oncol. 2021 Oct;121:105480. doi: 10.1016/j.oraloncology.2021.105480. Epub 2021 Aug 14. Oral Oncol. 2021. PMID: 34403888
17 results